Greenland Mines Ltd
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
Business Address
13576 WALNUT STREET, SUITE A, OMAHA, NE, 68144
Mailing Address
13576 WALNUT STREET, SUITE A, OMAHA, NE, 68144
Phone
(833) 931-6330
Fiscal Year End
1231
EIN
862727441
Financial Overview
FY2024
$1.62M
Total Liabilities
$64K
Cash & Equivalents
$-0.05
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | April 1, 2026 | View on SEC |
| 8-K Current report of material events | March 23, 2026 | View on SEC |
| 8-K Current report of material events | March 16, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | March 13, 2026 | View on SEC |
| 8-K Current report of material events | March 12, 2026 | View on SEC |
| 8-K Current report of material events | March 10, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
| 4 Insider stock transaction report | March 6, 2026 | View on SEC |
Annual Reports
10-K
April 1, 2026
- Strategic pivot into Arctic rare earth mineral exploration via the $12.5 million acquisition of Greenland Mines Corp.
- Advancement of the SUNRISE-PD gene therapy trial for Parkinson’s disease with data expected in late 2027.
Material Events
8-K
Financial Distress
March 23, 2026
High Impact
- Greenland Mines explores and develops critical minerals, including rare earth elements (REEs) and battery metals.
- Nasdaq granted Greenland Mines an extra six months, until September 14, 2026, to regain compliance with its $1 bid price rule.
8-K
Acquisition
March 16, 2026
High Impact
- Greenland Mines Ltd. (formerly Klotho Neurosciences) transformed into a diversified hybrid entity.
- Acquired Greenland Mines Corp., gaining one of the world's largest undeveloped critical metal deposits (Skaergaard Project) in Southeast Greenland.
8-K
Acquisition
March 4, 2026
High Impact
- Klotho Neurosciences acquired Greenland Mines Corp., pivoting from biotech to a diversified entity.
- The acquisition includes an 80% interest in the Skaergaard Project, one of the world's largest undeveloped critical mineral deposits.
8-K
Strategy Change
February 17, 2026
High Impact
- Shareholders authorized a reverse stock split to maintain Nasdaq listing and enhance market perception.
- Shareholders approved an expansion of the equity incentive plan by 10,000,000 shares to attract and retain top talent.
Related Companies
Companies in the same industry (SIC: 2836)
Scinai Immunotherapeutics Ltd.
SCNI
Biological Products, (No Diagnostic Substances)
Genenta Science S.p.A.
GNTA
Biological Products, (No Diagnostic Substances)
Kymera Therapeutics, Inc.
KYMR
Biological Products, (No Diagnostic Substances)
Innate Pharma SA
IPHA
Biological Products, (No Diagnostic Substances)
Black Hawk Acquisition Corp
BKHA
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.